STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma - Related Studies

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

This study is ongoing, but not recruiting participants.

Study NCT00006357. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Endometrial Cancer
		Gastrointestinal Stromal Tumor
		Ovarian Cancer
		Sarcoma
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Duodenal Neoplasms
		Endometrial Neoplasms
		Gastrointestinal Stromal Tumors
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Ileal Diseases
		Intestinal Diseases
		Jejunal Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Connective and Soft Tissue
		Ovarian Diseases
		Urogenital Neoplasms
		Uterine Diseases
		Uterine Neoplasms

4	Interventions listed in this trial
		imatinib mesylate

5	Additional drug interventions recognized in this trial
		Imatinib

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Kinase Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		European Organization for Research and Treatment of Cancer